TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 199 filers reported holding TRANSMEDICS GROUP INC in Q4 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,861 | -44.6% | 70,512 | -15.1% | 2.15% | -38.5% |
Q2 2023 | $6,971 | +10.9% | 83,012 | 0.0% | 3.50% | +9.2% |
Q1 2023 | $6,287 | +22.7% | 83,012 | 0.0% | 3.20% | +15.6% |
Q4 2022 | $5,123 | -99.8% | 83,012 | +1.6% | 2.77% | +40.0% |
Q3 2022 | $3,408,000 | -7.5% | 81,669 | -30.3% | 1.98% | -4.6% |
Q2 2022 | $3,684,000 | +16.8% | 117,160 | +0.1% | 2.08% | +43.2% |
Q1 2022 | $3,153,000 | +42.2% | 117,031 | 0.0% | 1.45% | +64.8% |
Q4 2021 | $2,218,000 | -42.7% | 117,031 | 0.0% | 0.88% | -34.5% |
Q3 2021 | $3,873,000 | -0.6% | 117,031 | -0.4% | 1.34% | +2.3% |
Q2 2021 | $3,898,000 | -12.6% | 117,471 | +9.3% | 1.31% | -21.2% |
Q1 2021 | $4,460,000 | +130.0% | 107,471 | +10.3% | 1.67% | +130.6% |
Q4 2020 | $1,939,000 | +43.2% | 97,471 | -0.9% | 0.72% | +17.2% |
Q3 2020 | $1,354,000 | -23.2% | 98,322 | -0.1% | 0.62% | -34.4% |
Q2 2020 | $1,763,000 | +380.4% | 98,388 | +224.0% | 0.94% | +115.3% |
Q1 2020 | $367,000 | +3570.0% | 30,369 | +5973.8% | 0.44% | +4270.0% |
Q4 2019 | $10,000 | – | 500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |